Seeking Alpha

QualityStocks'  Instablog

QualityStocks
Send Message
QualityStocks (www.qualitystocks.net) assists publicly traded companies by getting their story out to the investment community while helping investors discover emerging companies with plenty of growth potential. Our name, QualityStocks, emphasizes our commitment to connect subscribers with... More
My company:
QualityStocks
My blog:
QualityStocks Micro-Cap and Small-Cap Blog
  • AxoGen, Inc. (AXGN) Peripheral Nerve Repair Submission Receives Outstanding CTBS Abstract Award 0 comments
    Sep 7, 2012 5:31 PM | about stocks: AXGN

    AxoGen, a company engaged in the science and commercialization of surgical solutions for peripheral nerve repair, today announced that its submission on findings from the RANGER™ Registry, an on-going study for the Avance® Nerve Graft, was selected for an Outstanding CTBS Abstract Award and was accepted for poster display at the American, Keystone, Colo., September 8-10, 2012.

    Titled "Clinical Results from a Multicenter Registry Study on the Use of Processed Nerve Allograft for Sensory, Mixed and Motor Nerve Repairs," the abstract demonstrates the successful recovery of 87 percent of cases involving 66 patients and 92 injuries suffering peripheral nerve repair. The analysis shows no reported graft related complications, tissue rejections, or adverse events.

    According to Erick DeVinney, director of Clinical and Translational Sciences for AxoGen, the RANGER Study is the largest, multicenter observational study in peripheral nerve repair, and that receiving the Outstanding CTBS Abstract Award reflects the value of the outcome of the study.

    "We are very pleased to see these levels of meaningful recovery across sensory, motor and mixed nerves," DeVinney stated in the press release. "The selection by AATB for an Outstanding CTBS Abstract Award speaks to the importance of this study in demonstrating outcomes from peripheral nerve injuries repaired using processed nerve allograft."

    AxoGen said its Avance Nerve Graft is the only commercially available processed nerve allograft for surgically repairing peripheral nerve discontinuities.

    For more information visit axogeninc.com

    Please see disclaimer on the QualityStocks website: disclaimer.qualitystocks.net

    Stocks: AXGN
Back To QualityStocks' Instablog HomePage »

Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.

Comments (0)
Track new comments
Be the first to comment
Full index of posts »
Latest Followers

StockTalks

More »
Posts by Themes
Instablogs are Seeking Alpha's free blogging platform customized for finance, with instant set up and exposure to millions of readers interested in the financial markets. Publish your own instablog in minutes.